Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.
Park Lawn Corp. (PLC-T) said it has purchased two funeral homes, a crematorium and a discount funeral operation in B.C.'s Okanogan Valley.
"We are pleased to be making our first acquisition in the B.C. market with the purchase of Providence Funeral Homes and Credible Cremations in the Okanogan Valley," stated CEO Andrew Clark in a release. "We believe that this market shares similar characteristics to the other markets in which we operate in Canada."
InterRent Real Estate Investment Trust (IIP.UN-T) reported fourth-quarter net operating income of $14.5-million up 10 per cent from $13.2-million a year earlier.
Funds from operations were $7.3-million or 10.1 cents per unit compared to $6.5-million or 9 cents a year earlier.
Dream Industrial REIT (DIR.UN-T) reported fourth-quarter net operating income of $28.8-million versus $29.9-million a year earlier.
Investment property revenue was $42.7-million versus $44.5-million a year earlier.
Funds from operations were $16.7-million or 21.2 cents per unit compared to $18.7-million or 23.7 cents per unit a year earlier.
Adjusted funds per unit came in at 18.6 cents compared to 20.7 cents a year earlier.
Golden Star Resources Ltd. (GSS-N; GSC-T) reported fourth-quarter net income attributable to shareholders of $3.4-million or a penny income per share, compared to a net income of $13.8-million or 5 cents per share a year earlier.
The decrease was "due to lower mine operating margin at Wassa and lower other income," the company said.
Adjusted net earnings attributable to shareholders1 was $100,000 compared to adjusted net earnings of $7-million for the same period in 2015.
"This lower adjusted net earnings was due to the mine operating loss at Wassa in the fourth quarter of 2016 resulting from lower revenue from gold sales attributable to the Wassa Main Pit," the company said.
Analysts were expecting a loss of a penny per share.
Sandstorm Gold Ltd. (SAND-N; SSL-T) reported fourth-quarter revenue of $16.5-million (U.S.) up from $9.9-million a year earlier.
It sold a record 13,245 ounces of gold, versus 8,951 ounces a year earlier.
Its net loss of $0.02 million versus a loss of $25-million a year earlier.
Analysts were expecting revenues of $17-million.
Summit Industrial Income REIT (SMU.UN-T) reported fourth-quarter operating revenues of $12.8-million versus $9.7-million a year earlier.
Net operating income rose to $8.3-million in the fourth quarter ended Dec. 31, compared to $6.7-million a year earlier.
Funds from operations were $5.5-million or 15.7 cents per unit compared to $4.3-million or 15 cents a year earlier.
5N Plus Inc. (VNP-T) reported fourth-quarter revenue of $54.7-million (U.S.) compared to $59.4-million a year earlier.
Adjusted EBITDA was $4.3-milllion versus $674,000 a year earlier.
Analysts were expecting revenue of $54.3-million
Killam Apartment REIT (KMP.UN-T) is raising $70-million in a bought-deal financing.
It has an agreement with a syndicate of underwriters to buy 5.5 million units for $12.65 each.
Killam said it intends to use the net proceeds to redeem convertible subordinated debentures, to partially fund the previously announced $49-million apartment acquisition in Ottawa and for potential future acquisitions.
Osisko Mining Inc. (OSK-T) filed an early warning report regarding its holdings in Beaufield Resources Inc.
On Feb. 21, Osisko, through its wholly-owned subsidiary O3 Investments Inc., bought 31.7 million shares of Beaufield in a brokered private placement at 10 cents per share.
It now owns about 16.4 per cent of Beaufield "for investment purposes."
Osisko Gold Royalties Ltd (OR-T; OR-N) says it has subscribed for and received about 8.3 common shares of QMX Gold Corp. (QMX-T) at a price of 30 cents per share, in connection with the closing by QMX of its previously announced private placement.
Osisko Gold said it now owns about 23.3 million shares of OMX, representing approximately 16.5 per cent of the company.
Canopy Growth Corp (WEED-T) said it begin selling cannabis seeds to authorized home growers under the Access to Cannabis for Medical Purposes Regulations in early March.
The company said its Tweed subsidiary will become the second producer in Canada to offer a seed option.
Alimera Sciences, Inc. (ALIM-Q) and Knight Therapeutics Inc. (GUD-T) announced that Knight's New Drug Submission for ILUVIEN has been accepted for review by Health Canada.
The drug is Alimera's sustained release intravitreal implant approved in the U.S. to treat diabetic macular edema (DME), the company said.
"ILUVIEN is a unique and innovative product that is available in different markets around the world, including the U.S. and Europe," said Knight CEO Jonathan Ross Goodman.
Knight and Alimera signed an agreement in July 2015 granting Knight the exclusive right to distribute ILUVIEN in Canada.
VBI Vaccines Inc. (VBIV-Q; VBV-T) said the Biologics and Genetic Therapies Directorate (BGTD) of Health Canada expressed its "general support and acceptance" of the company's development path for its Sci-B-Vac vaccine against hepatitis B in a pre-clinical trial application (CTA) meeting.
"A complete CTA must be filed with and approved by BGTD, and all conditions of BGTD must be met, prior to the initiation of a clinical program in Canada," the company said.